Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor ActivationBrent A. McLean, Daniel J. Drucker, Chi Kin Wong et al.|Endocrine Reviews|2020Cited by 268
Central glucagon-like peptide 1 receptor activation inhibits Toll-like receptor agonist-induced inflammationChi Kin Wong, Daniel J. Drucker, Julian M. Yabut et al.|Cell Metabolism|2023Cited by 251
Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammationChi Kin Wong, Daniel J. Drucker, Dianne Matthews et al.|Cell Metabolism|2022Cited by 121
Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutideBrent A. McLean, Daniel J. Drucker, Chi Kin Wong et al.|JCI Insight|2021Cited by 74
Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarctionBrent A. McLean, Daniel J. Drucker, Chi Kin Wong et al.|Molecular Metabolism|2022Cited by 73